1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Post Restructuring Meetings

Discussion in 'Takeda IT' started by Anonymous, Dec 19, 2010 at 9:37 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Please cease with the post restructuring meetings until after it actually occurs. It is quite demeaning when Lee's direct reports are touting their own accomplishments and joking about "tickets to gun shows" and having someone count out how many analogies are made in a given glory speech. Are you all that ignorant even after Lee stood up before it started and made it a point to say that people may be more sensitive than usual? The IT department is really beginning to show its true colors. Bunch of machines.
     

  2. Anonymous

    Anonymous Guest

    Any futher updates???